Accelerated Metabolomic Age and Its Association with Social Determinants of Health in Multiple Sclerosis

Medicare Part D Utilization, Spending, and Formulary Coverage of Brand-name Disease Modifying Therapies with Generics Available for Multiple Sclerosis